Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 406-750-9 | CAS number: 129757-67-1 TINUVIN 123
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Assessment of the Toxicokinetic Behaviour (EC No. 406 -750 -9)
There were no studies available in which the toxicokinetic properties of the test item were investigated.
The test item is a yellow colored liquid mixture with a molecular weight of 685 Da (see chapter 1 general information). The test substance is of low volatility (see chapter 4.6), very low water solubility (< 6 mg/L at 20°C (see chapter 4.8 water solubility)) and has an n-octanol-water partition coefficient (log Pow) of >10 at 25 °C (see chapter 4.7 partition coefficient). The substance is not readily biodegradable. A general accumulation of the test substance in humans may be low because it’s a high lipophilic molecule and because of the sterically reasons.
Absorption
Slight effects were noted in the 28-day and 90-day repeated dose studies that were reversible after a subsequent four-week period without treatment. Therefore, bioavailability of the test substance to some degree is indicated after oral administration. Physico-chemical properties do not support a potential for systemic exposure of the test item.
In line with the low acute oral and dermal toxicity of the test substance are physico-chemical properties: as a highly lipophilic molecule the test substance might be poorly absorbed from the gastrointestinal tract and its bioavailability is expected to be low as indirectly proven by the absence of slight degree of toxicity. Due to the high molecular weight and the very low water solubility the dermal absorption is also considered as low.
The test item has a comparably low vapour pressure of 3.6E-4 Pa at 25°C (CIBA-Geigy, see chapter 4.6 vapour pressure); subsequently, the calculated vapour saturation threshold is ca. 0.00011 mg/L. Therefore, relevant human exposure of the substance via the inhalative route is not assumed.
Metabolism
Information about potential metabolites is not available. Genotoxicity studies did not reveal a difference in the results with or without application of the S9 -mix. The test item has very low water solubility (< 6 mg/L) but may not be hydrolytically resistant. Hydrolysis reactions are suggested under the conditions in the gastro-intestinal tract and cleavage products may be much better absorbed than the parent substance through the intestinal wall. Similar reactions are suggested to occur in the liver. Hydrolytic cleavage of the acyclic carboxylic esters is predicted, followed by glucuronidation and/or elimination.
Theoretically, an accumulation might occur in the lipid-rich tissues due to the high lipophility. However, the proportion of the substance that enters systemic circulation unchanged is considered as extremely low. Furthermore, it can only be concluded from the reversibility of the observed effects in the subacute and subchronic repeated dose studies that the test substance does not accumulate in the body.
Excretion
There is no information available about potential metabolites.
High molecular weight and the low water solubility indicate biliary excretion. The cleavage products however may be subject to urinary excretion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.